Philadelphia Cardiology Inc is categorized under Cardiologists in Philadelphia, PA and active since 1982.
Philadelphia Cardiology Inc was established in 1982, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Arnold B Meshkov at the company’s headquarters by writing to 9501 Roosevelt Boulevard # 305, Philadelphia, Pennsylvania PA 19114 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Philadelphia Cardiology Inc |
| Contact Person: | Arnold B Meshkov |
| Address: | 9501 Roosevelt Boulevard # 305, Philadelphia, Pennsylvania 19114 |
| Website Address: | ccpdocs.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1982 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Cardiologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Philadelphia Cardiology Inc was started in 1982 to provide professional Cardiologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Arnold B Meshkov for inquiries that concern Philadelphia Cardiology Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Philadelphia Cardiology Inc can be found at the coordinates 40.080808,-75.02812 as well as the street address 9501 Roosevelt Boulevard # 305 in Philadelphia, Pennsylvania 19114.
For its online presence, you may visit Philadelphia Cardiology Inc’s website at ccpdocs.com and engage with its social media outlets through on Twitter and on Facebook.